| Lindsey Brooke Mccallon, OD | |
|
2900 E University Dr Ste 110, Auburn, AL 36830-7729 | |
| (334) 539-5391 | |
| Not Available |
| Full Name | Lindsey Brooke Mccallon |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 3 Years |
| Location | 2900 E University Dr Ste 110, Auburn, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760158257 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | SE72TAC31 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mayfield Family Eyecare, Llc | 2365603701 | 2 |
News Archive
Arcadia Capital Advisors Managing Director Richard Rofé announced today that he has commenced a $16.00 per share all-cash tender offer for CPEX Pharmaceuticals, Inc. through RSR Acquisition Co., a wholly-owned subsidiary of Shelter Bay Holdings, LLC.
Aberrant activation of the Hedgehog (Hh) pathway has been associated with numerous malignancies including basal cell carcinoma, medulloblastoma, and pancreatic cancer. Several reports also suggest that positive regulators of the Hh pathway could be used in the treatment of neurodegenerative diseases.
"While there was a suggestion that difluoromethylornithine (DFMO) may influence the extent of Barrett's dysplasia, this finding is very preliminary and further study of this agent in a larger number of patients is needed," said Frank A. Sinicrope, M.D., professor of medicine and oncology at the Mayo Clinic, Rochester, MN.
Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today announced that its MARINE trial, a Phase 3 clinical trial of AMR101, has completed patient enrollment and randomization into the treatment phase of this trial. The Company indicated that top line results from this trial are expected early in 2011, towards the early part of the range of guidance provided previously.
› Verified 3 days ago
| Provider Name | Mayfield Family Eyecare, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1649546953 PECOS PAC ID: 2365603701 Enrollment ID: O20120412000199 |
News Archive
Arcadia Capital Advisors Managing Director Richard Rofé announced today that he has commenced a $16.00 per share all-cash tender offer for CPEX Pharmaceuticals, Inc. through RSR Acquisition Co., a wholly-owned subsidiary of Shelter Bay Holdings, LLC.
Aberrant activation of the Hedgehog (Hh) pathway has been associated with numerous malignancies including basal cell carcinoma, medulloblastoma, and pancreatic cancer. Several reports also suggest that positive regulators of the Hh pathway could be used in the treatment of neurodegenerative diseases.
"While there was a suggestion that difluoromethylornithine (DFMO) may influence the extent of Barrett's dysplasia, this finding is very preliminary and further study of this agent in a larger number of patients is needed," said Frank A. Sinicrope, M.D., professor of medicine and oncology at the Mayo Clinic, Rochester, MN.
Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today announced that its MARINE trial, a Phase 3 clinical trial of AMR101, has completed patient enrollment and randomization into the treatment phase of this trial. The Company indicated that top line results from this trial are expected early in 2011, towards the early part of the range of guidance provided previously.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lindsey Brooke Mccallon, OD 2900 E University Dr Ste 110, Auburn, AL 36830-7729 Ph: (334) 539-5391 | Lindsey Brooke Mccallon, OD 2900 E University Dr Ste 110, Auburn, AL 36830-7729 Ph: (334) 539-5391 |
News Archive
Arcadia Capital Advisors Managing Director Richard Rofé announced today that he has commenced a $16.00 per share all-cash tender offer for CPEX Pharmaceuticals, Inc. through RSR Acquisition Co., a wholly-owned subsidiary of Shelter Bay Holdings, LLC.
Aberrant activation of the Hedgehog (Hh) pathway has been associated with numerous malignancies including basal cell carcinoma, medulloblastoma, and pancreatic cancer. Several reports also suggest that positive regulators of the Hh pathway could be used in the treatment of neurodegenerative diseases.
"While there was a suggestion that difluoromethylornithine (DFMO) may influence the extent of Barrett's dysplasia, this finding is very preliminary and further study of this agent in a larger number of patients is needed," said Frank A. Sinicrope, M.D., professor of medicine and oncology at the Mayo Clinic, Rochester, MN.
Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today announced that its MARINE trial, a Phase 3 clinical trial of AMR101, has completed patient enrollment and randomization into the treatment phase of this trial. The Company indicated that top line results from this trial are expected early in 2011, towards the early part of the range of guidance provided previously.
› Verified 3 days ago
Dr. Andrea Hardwick, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 778 N Dean Rd Ste 100, Auburn, AL 36830 Phone: 334-887-2224 | |
Moores Mill Eyecare Pc Optometrist Medicare: Medicare Enrolled Practice Location: 2415 Moores Mill Rd, Suite 220, Auburn, AL 36830 Phone: 334-521-7944 Fax: 334-521-7277 | |
Dr. Brett Alan Basden, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 780 N Dean Rd, Auburn, AL 36830 Phone: 334-887-6621 Fax: 334-826-2059 | |
Valley Eye Associates, Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5116 Heath Rd, Auburn, AL 36830 Phone: 334-468-0698 Fax: 334-502-1453 | |
Dr. Loretta D. James, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1627 Opelika Rd Ste 100, Auburn, AL 36830 Phone: 334-826-6779 | |
Auburn Eye Care Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1955 Opelika Rd, Auburn, AL 36830 Phone: 334-821-8889 Fax: 334-821-4733 | |
Auburn Eye Care Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1955 Opelika Rd, Auburn, AL 36830 Phone: 334-821-8889 |